And the beat goes onis a refrain that kept rolling through my head after attending the symposium Tuesday hosted by the Womens Institute for a Secure Retirement (WISER) in Washington, D.C. The topic: retirement solutions for women.
Unlike the financial sector that dominated Crescent’s 2016 returns, there wasn’t any one sector that was an unusual driver of performance year to date. However, Arconic (NYSE:ARNC) was one company that did stand out, increasing 42.41% in the quarter, which added 0.73% to the Fund’s first-quarter return.
Arconic’s recent stock price performance was neither a function....More>>>
Gold prices finished in negative territory Monday as the dollar strengthened and as investors favored assets perceived as risky over so-called havens.
Gold has been plagued by a downbeat tone in the wake of recent signals from the Federal Reserve for at least one more increase to interest rates this year in what has been interpreted as an upbeat outlook on the worlds No. 1 economy. That view....More>>>
Never a boring day — that’s been the de facto mantra of the administration of President Donald Trump. But over the weekend, he may have taken things a bit too far. In a series of tweets, Donald Trump accused his predecessor, former President Barack Obama, of wiretapping his phones. A day later, the White House called for a congressional investigation as to whether Obama meddled in last....More>>>
It’s far better to buy a wonderful company at a fair price than a fair company at a wonderful price. Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down. – Warren Buffett
What is a wonderful company, and what is ‘quality’ from an investing standpoint? The most constructive definition to address these questions....More>>>
UBS analyst Michael Lasser and team ask when the acquisition of Jet.com will be profitable for Wal-Mart Stores (WMT):
To size the impact to Wal-Marts P&L, we assume Jet achieves $1b in GMV over the next 12 mos & its 3P commissions are ~10%. This implies ~$400m in rev. Also, we est. a gross margin of 20% (assuming a ~10% GM on 1P & ~75% on 3P). News reports....More>>>
On Friday, small cap biotechArrowhead Pharmaceuticals (NASDAQ: ARWR) jumped 18.28% after hosting an investor & analyst R&D day to introduce its proprietary Targeted RNAi Molecule (TRiMTM) platform and to review its pipeline of RNAi therapeutic candidates. Arrowhead Pharmaceuticals develop